Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.10 +0.07 (+3.45%)
As of: Oct 22, 2026 · 11:58 AM EDT

Acumen Pharmaceuticals (ABOS) Other financing activities (2022 - 2026)

Updated

Acumen Pharmaceuticals' Other financing activities was $149,000 in Q1 2026, up 104.1% from $73,000 a year earlier.

Analysis

Acumen Pharmaceuticals (ABOS) Other financing activities (2022 - 2026) Analysis & Trends

For FY2025, Other financing activities at Acumen Pharmaceuticals came in at $73,000, up 78.0% from FY2024.

  • In earlier years, Other financing activities was $41,000 in FY2024 (-91.4%) and $476,000 in FY2023.
  • The Q1 2026 figure marks the highest quarterly Other financing activities since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,170.64 Bn 1,139.22 Bn 19.71 Bn
2 Johnson & Johnson 640.54 Bn 559.06 Bn 17.26 Bn
3 AbbVie 501.78 Bn 474.89 Bn 12.70 Bn
4 Merck 374.95 Bn 329.32 Bn 12.21 Bn
5 Novartis Ag 302.43 Bn 266.42 Bn 11.24 Bn
6 Astrazeneca 268.31 Bn 241.99 Bn 12.86 Bn
7 Amgen 242.70 Bn 198.10 Bn 7.24 Bn
8 Gilead Sciences 193.64 Bn 167.84 Bn 6.22 Bn
9 Pfizer 172.34 Bn 118.98 Bn 10.94 Bn
10 Acumen Pharmaceuticals 151.73 Mn -330.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -149,000.00
Mar 31, 2025 -73,000.00
Dec 31, 2024 -9,000.00
Sep 30, 2024 -42,000.00
Jun 30, 2024 -128,000.00
Mar 31, 2024 -92,000.00
Dec 31, 2023 -476,000.00
Sep 30, 2023 145,000.00
Jun 30, 2023 -145,000.00
Dec 31, 2022 296,000.00
Sep 30, 2022 -265,000.00
API Access

Acumen Pharmaceuticals Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ABOS&period=max&api_key=YOUR_API_KEY